Last reviewed · How we verify
NCT06061744
Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer
trial testing Minimally invasive surgery in Gallbladder Cancer in 600 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | Hospital del Mar |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 1 April 2023 |
| Primary completion | 1 December 2023 |
| Estimated completion | 30 January 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Minimally invasive surgery
Conditions studied
- Gallbladder Cancer — all drugs for Gallbladder Cancer →
Sponsor
Hospital del Mar
Who can join
18 and older, any sex, with Gallbladder Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The gallbladder is the most common primary cancer site among the biliary tracts and its incidence is increasing. Its prognosis is still poor with a 5-year survival of almost 20%. Cholecystectomy is curative in patients with Tis and T1a. For patients with resectable T1b and above disease, radical cholecystectomy is advocated consisting of en bloc resection of the gallbladder, wedge resection of the liver or segment 4b, extrahepatic bile duct, and the regional lymph nodes. The aim of this study is to compare patients who have undergone Robotic, Laparoscopic and Open liver resection with lymphadenectomy for \>T1b gallbladder cancers in a case-matched analysis using propensity scores. The primary endpoints are intra- and postoperative outcomes, and the secondary endpoints long-term oncologic outcomes and feasibility and adequacy of minimally invasive versus traditional open approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06061744
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Minimally invasive surgery
Trials testing the same drug.
- NCT05999162 — Mechanical Ileus in the Era of Minimally Invasive Colorectal Surgery · completed
- NCT05179109 — Robotic Versus Laparoscopic Surgery for Deep Endometriosis · NA · recruiting
- NCT05015036 — Evaluation of an Enhanced Recovery Protocol After Minimally Invasive Lumbar Surgery. · terminated
- NCT04693767 — Investigation of Clot in Ischemic Stroke and Hematoma Evacuation · completed
- NCT04606823 — Ponto Implantation Using a Minimally Invasive Surgical Technique · NA · completed
Other recruiting trials for Gallbladder Cancer
Currently open trials in the same condition.
- NCT06717464 — Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepa · Phase 2 · active not recruiting
- NCT05757336 — Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer · Phase 2 · recruiting
- NCT05833815 — Addition of Everolimus to Standard of Care in Carcinoma Gallbladder · Phase 2, PHASE3 · recruiting
- NCT04907643 — Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · NA · recruiting
- NCT04308174 — Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer · Phase 2 · active not recruiting
Other Hospital del Mar trials
Trials by the same sponsor.
- NCT07481760 — Acute Cholecystitis Biliary Complications - ICG · NA · not yet recruiting
- NCT07208994 — Pathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol · not yet recruiting
- NCT06981273 — Robotic vs Open Pancreatoduodenectomy · NA · not yet recruiting
- NCT06765044 — Textbook Outcomes in Urgent Appendectomy · not yet recruiting
- NCT06228027 — External Validation os the ACME Scoring System · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06061744 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital del Mar
- Last refreshed: 29 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06061744.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing